Semler Scientific (Nasdaq:SMLR) - Cotización, noticias y análisis

Resumen de acción SMLR

Semler Scientific, Inc. ofrece soluciones tecnológicas para mejorar la eficacia y eficiencia clínicas de los profesionales sanitarios en Estados Unidos.

Acerca de la empresa

Análisis fundamental de SMLR
Puntuación del snowflake
Valoración	4/6
Crecimiento futuro	0/6
Rendimiento pasado	2/6
Salud financiera	6/6
Dividendos	0/6

Recompensas

Trading at 47.1% below our estimate of its fair value

Análisis de riesgos

High level of non-cash earnings

Significant insider selling over the past 3 months

Competidores de Semler Scientific, Inc.

Electromed

NYSEAM:ELMD

US$192.5m

Zynex

NasdaqGS:ZYXI

US$279.0m

Tactile Systems Technology

NasdaqGM:TCMD

US$352.1m

Jin Medical International

NasdaqCM:ZJYL

US$320.9m

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Semler Scientific
Precios históricos de las acciones
Precio actual de la acción	US$30.68
Máximo en las últimas 52 semanas	US$53.38
Mínimo de 52 semanas	US$20.88
Beta	0.96
1Cambio en 1 mes	22.77%
Variación en 3 meses	11.48%
Cambio de 1 año	4.25%
3Variación en 3 años	-72.83%
Variación en 5 años	-32.57%
Variación desde la OPV	338.91%

Noticias y actualizaciones recientes

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Nov 02

Recent updates

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Nov 02

Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

Aug 14

The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

Jul 18

We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

May 08

Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade

Mar 08

Semler Scientific: Why I'm Buying

Mar 05

Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?

Mar 02

Semler's Unique Business Model Is Fueling Profitable Growth

Feb 23

Better Price For Semler Is Likely

Jan 05

Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem

Nov 12

It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To Peers

Oct 15

Semler Scientific: Rapidly Growing Medical Device Company

Oct 14

There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price Jump

Oct 14

Rentabilidad de los accionistas

	SMLR	US Medical Equipment	Mercado US
7D	3.8%	0.2%	-1.6%
1Y	4.2%	25.8%	30.8%

Rentabilidad vs. Industria: SMLR underperformed the US Medical Equipment industry which returned 25.8% over the past year.

Rentabilidad vs. Mercado: SMLR underperformed the US Market which returned 30.8% over the past year.

Volatilidad de los precios

Is SMLR's price volatile compared to industry and market?
SMLR volatility
SMLR Average Weekly Movement	8.6%
Medical Equipment Industry Average Movement	8.0%
Market Average Movement	6.0%
10% most volatile stocks in US Market	14.9%
10% least volatile stocks in US Market	2.9%

Precio estable de las acciones: SMLR has not had significant price volatility in the past 3 months compared to the US market.

Volatilidad a lo largo del tiempo: SMLR's weekly volatility (9%) has been stable over the past year.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2007	92	Doug Murphy-Chutorian	www.semlerscientific.com

Semler Scientific, Inc. ofrece soluciones tecnológicas para mejorar la eficacia y eficiencia clínicas de los profesionales sanitarios en Estados Unidos. Los productos de la empresa incluyen QuantaFlo, una prueba de flujo sanguíneo de cuatro minutos que permite a los profesionales sanitarios utilizar mediciones de flujo sanguíneo como parte de sus exámenes de la condición vascular de un paciente. También ofrece Insulin Insights, un programa informático utilizado por los profesionales sanitarios para optimizar la dosificación de insulina en pacientes ambulatorios.

Resumen de fundamentos de Semler Scientific, Inc.

¿Cómo se comparan los beneficios e ingresos de Semler Scientific con su capitalización de mercado?
Estadísticas fundamentales de SMLR
Capitalización bursátil	US$214.52m
Beneficios(TTM)	US$15.82m
Ingresos (TTM)	US$61.74m

13.6x

Ratio precio-beneficio (PE)

3.5x

Ratio precio-ventas (PS)

¿Está SMLR sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de SMLR
Ingresos	US$61.74m
Coste de los ingresos	US$7.00m
Beneficio bruto	US$54.74m
Otros gastos	US$38.93m
Beneficios	US$15.82m

Últimos beneficios comunicados

Jun 30, 2024

Próxima fecha de beneficios

Nov 04, 2024

Beneficios por acción (BPA)	2.26
Margen bruto	88.67%
Margen de beneficio neto	25.62%
Ratio deuda/patrimonio	0%

¿Cómo se ha desempeñado SMLR a largo plazo?

Ver rendimiento histórico y comparativa

Resumen de acción SMLR

Recompensas

Análisis de riesgos

Competidores de Semler Scientific, Inc.

NYSEAM:ELMD

US$192.5m

NasdaqGS:ZYXI

US$279.0m

NasdaqGM:TCMD

US$352.1m

NasdaqCM:ZJYL

US$320.9m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Investor sentiment improves as stock rises 22%

Semler Scientific, Inc. to Report Q3, 2024 Results on Nov 04, 2024

CEO, President & Director recently sold US$306k worth of stock

CEO, President & Director exercised options to buy US$2.0m worth of stock.

Semler Scientific, Inc., Annual General Meeting, Oct 04, 2024

Recent updates

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Investor sentiment improves as stock rises 22%

Semler Scientific, Inc. to Report Q3, 2024 Results on Nov 04, 2024

CEO, President & Director recently sold US$306k worth of stock

CEO, President & Director exercised options to buy US$2.0m worth of stock.

Semler Scientific, Inc., Annual General Meeting, Oct 04, 2024

Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$0.002 (vs US$0.88 in 2Q 2023)

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 20%

Semler Scientific, Inc. to Report Q2, 2024 Results on Aug 05, 2024

The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

Semler Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Investor sentiment improves as stock rises 36%

Investor sentiment improves as stock rises 38%

Investor sentiment deteriorates as stock falls 17%

New minor risk - Shareholder dilution

Price target decreased by 38% to US$40.00

First quarter 2024 earnings: EPS and revenues miss analyst expectations

We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

Semler Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024

Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)

New minor risk - Shareholder dilution

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorates as stock falls 18%

Now 25% undervalued after recent price drop

Semler Scientific, Inc. to Report Q4, 2023 Results on Mar 05, 2024

Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?

Investor sentiment improves as stock rises 16%

Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Investor sentiment improves as stock rises 33%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Shareholder dilution

Semler Scientific, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Semler Scientific, Inc. Announces Steps Down of Abbie" Leibowitz as Class II Director

Investor sentiment improves as stock rises 15%

Semler Scientific, Inc., Annual General Meeting, Oct 19, 2023

Semler Scientific, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Investor sentiment improves as stock rises 24%

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 26% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Semler Scientific, Inc. Announces Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible

Investor sentiment improved over the past week

Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Price target decreased to US$55.00

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Semler Scientific Updates Financial Guidance for the Year Ending December 31, 2022

Semler Scientific, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Semler Scientific, Inc., Annual General Meeting, Oct 20, 2022

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Second quarter 2022 earnings: EPS exceeds analyst expectations

Semler Scientific, Inc. Provides Earnings Guidance for Second Half and Full Year Ended December 31, 2022

Semler Scientific: Growth, Profits, And Valuation Models Support A Buy

Investor sentiment improved over the past week

Semler Scientific, Inc. to Report Q2, 2022 Results on Aug 02, 2022